![The new platform can modify the RNA of cells, boosts the cells’ ability to target tumors – Cancer Research Institute (CRI)](https://oncodaily.com/pub/uploads/2024/04/ef844413ed5e4cb2a365aec62637537e.jpg)
Photo from Cancer Research Institute (CRI)/LinkedIn
Apr 11, 2024, 15:04
The new platform can modify the RNA of cells, boosts the cells’ ability to target tumors – Cancer Research Institute (CRI)
Quoting Cancer Research Institute (CRI) on LinkedIn:
”According to a study from Stanford University researchers, cell therapies for cancer can be potentially enhanced using a CRISPR RNA-editing platform.
The new platform, Multiplexed Effector Guide Arrays (MEGA), can modify the RNA of cells, allowing researchers to regulate immune cell metabolism in a way that boosts the cells’ ability to target tumors.
Although MEGA is still in its early stages, researchers hope that it will eventually be applied in clinical settings. Learn more.”
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 1, 2024, 17:00